O'BRIEN MORENCY: Open Payments
NPI 1750923694 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$394 in 11 payments from 4 companies in 2025. Trend: 2023 $441 · 2024 $451 · 2025 $394
Food & beverage: $394
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 7 | $232 |
| ABBVIE INC. | 2 | $98 |
| Madrigal Pharmaceuticals | 1 | $33 |
| Intercept Pharmaceuticals, Inc. | 1 | $31 |
Products named: MAVYRET, REZDIFFRA, OCALIVA.
Industry payments across NY — which companies pay providers there.
